Education > Article > Finding Harmony with our Virome

Finding Harmony with our Virome

The personal and global toll of the COVID-19 pandemic is sobering, especially on mental health as summarised in an important article by Professor Sir Graham Thornicroft, Professor of Community Psychiatry at King’s College London. The emerging problem of coronavirus ‘long-haulers’ is equally concerning. Amidst all of the upheaval and uncertainty, it is important to take a step back, breathe, and focus on what is within our control. This most certainly includes our nutrition and lifestyle.

Harmonising our human-viral interactions

The personal and global toll of the COVID-19 pandemic is sobering, especially on mental health as summarised in an important article by Professor Sir Graham Thornicroft, Professor of Community Psychiatry at King’s College London1. The emerging problem of coronavirus ‘long-haulers’ is equally concerning2. Amidst all of the upheaval and uncertainty, it is important to take a step back, breathe, and focus on what is within our control. This most certainly includes our nutrition and lifestyle.

Viruses are one of the most abundant entities on earth and represent an important part of the microbial community with which we live in symbiosis, for better or worse. We are exposed to a combination of beneficial and pathogenic strains which can go on to inhabit different parts of our bodies, including our gastrointestinal and respiratory tract. Together they form what is known as our virome3,4. Given the ubiquitous nature of our exposure to viruses, it is vital that we find a way to harmonise the human-viral interaction to facilitate our adaptation to the world that we live in.

In our previous article about optimising immunity, we discussed the importance of supporting our immune system from both the ‘outside-in’ and the ‘inside-out’. This approach is particularly pertinent when it comes to viruses as it helps to make the ecosystem of the human body as resilient as possible to pathogenic viral invasion and replication. In this article, we discuss some of the best-researched natural therapeutics for optimising our endogenous anti-viral defences.

It goes without saying that we must minimise our exposure to viruses through social distancing and personal hygiene to minimise the viral load (amount of measurable virus), which our immune system needs to contend with. We need to go one step further by making it harder for viruses, whether ingested or inhaled, to permeate our membranes (e.g., in the lungs) where they initiate a powerful immune response and symptoms of illness. We can achieve this by ensuring that we have a robust system of mucosal and epithelial barriers, ready on standby, at each point of entry into the body, namely the oral cavity and gastrointestinal, reproductive, and respiratory tracts. A fundamental starting point is optimisation of the microbiotas, and structure of the barriers, in these different parts of the body using a synergistic combination of prebiotics, probiotics, and micronutrients.

The likes of vitamin A, C, D, and zinc are heavily discussed in relation to how they support systemic immunity against viruses, but they deserve an equal amount of attention for their role in shoring up our barrier defences. Vitamin A, D, and zinc can improve the integrity of the gut and lung epithelial barrier, for example, by upregulating epithelial cell differentiation and tight junction proteins5–9. Vitamin C can also support tight junction function, as well as enhance synthesis of collagen, a vital raw material for the structure of the epithelial barrier10. Vitamin A and zinc support the function of the mucosal barrier too by increasing its composition of secretory IgA (SIgA)11 and anti-microbial peptides12, respectively.

The anti-viral potential of these trusty micronutrients, together with prebiotics and probiotics, needs to be fully harnessed. It is therefore gratifying to see that vitamin C, D, and zinc are receiving well-deserved mainstream attention in light of the COVID-19 pandemic13–15 and that the conversation is growing around the promise of microbiome modulation too16,17.

Research continues to highlight the plethora of risk factors that can increase the chance of severe viral infections, not least COVID-19. These range from micronutrient insufficiency, especially vitamin C, D, and zinc, to gut dysbiosis18, poor metabolic health (e.g. obesity, blood glucose dysregulation)19, sleep apnoea20, and mental health issues21. Improving such parameters through nutrition and lifestyle increases immune resilience at a deep level. It is also clinically beneficial to complement such systemic immune support with targeted nutraceuticals, shown to directly reduce pathogenic viral loads and efficiently modulate the innate and adaptive immune system against viruses.

Andrographis (Andrographis paniculata) is a herb indigenous to tropical regions, especially India and Sri Lanka, with a strong history of traditional use for immunity22. Momentum is building within the research community about the immune significance of Andrographis. In a recent review of 33 randomised clinical trials (n=7,175), it was found to improve coughs and reduce sore throat and overall symptoms and duration of acute upper respiratory tract symptoms23. As such, it was mentioned in the 2019 National Institute for Health and Care Excellence (NICE) guidelines as a promising over-the-counter remedy for the management of coughs, while helping to combat the growing issue of anti-microbial resistance caused by excessive use of antibiotics. Results are also awaiting from a recent clinical trial run in the NHS in conjunction with Southampton University on the use of this herb to manage sore throats, coughs, and colds. Unsurprisingly, it is currently being discussed for its utility in light of the COVID-19 pandemic as well24,25. Andrographis has various anti-viral modes of action, including the ability to block the binding of several influenza viruses to cells, thus inhibiting their ability to replicate26.

Various Echinacea species such as E. angustifolia and E. purpurea have a history of use in traditional and contemporary medicine for immune support, particularly against viruses. An in vitro study from 2009 demonstrated its ability to inhibit replication of the influenza virus, including seasonal strains that cause the flu and strains of highly pathogenic avian and swine influenza viruses27. In turn, a meta-analysis in 2015 (n=2,458) found that the use of Echinacea extracts was associated with a reduced risk of recurrent respiratory infections and that increased dosing during acute infection conferred additional benefits28.

L-lysine is an essential amino acid with a well-recognised ability to confer protection against viruses, specifically the herpes simplex virus which is a common cause of facial cold sores and genital sores. Replication of the herpes virus requires an adequate supply of another amino acid, arginine. L-Lysine competes with arginine in the body and thus, helps to starve herpes virus replication. In doing so, L-lysine supplementation, ideally alongside a low-arginine diet, may help to prevent an outbreak and reduce the severity of symptoms in some individuals, particularly when a higher dosage is taken acutely29.

Medicinal Mushrooms
Medicinal mushrooms are another promising anti-viral tool. This is a class of fungi shown to elicit benefits for human health following consumption, including for the immune system. Medicinal mushrooms include well-researched species such as Cordyceps spp., Hericium erinaceus (lion’s mane mushroom), Lentinula edodes (shiitake), Trametes versicolor (turkey tail mushroom), Grifola frondosa (maitake mushroom), Poria cocos (Indian bread mushroom), Agaricus blazei (royal sun agaricus), and Ganoderma lucidum (reishi)30. Reishi, for example, has been proposed as a promising anti-viral given its inhibitory effect on HIV-1, herpes simplex virus type 1 and 2, hepatitis B, and vesicular stomatitis virus31. Various other medicinal mushrooms have the potential for inhibiting viral replication and reducing the pathogenic viral load, as well as enhancing the cellular and humoral immune response to infection, including Cordyceps spp.32.

Given the viral challenge we face, it is imperative that we learn to co-exist with viruses, even the pathogenic strains, by shoring up our anti-viral immune defences. Natural interventions hold great promise in this regard in both a preventive and acute scenario, whereby higher dosages can be helpful during the case of active infections. Furthermore, given the ever-changing nature of viruses due to their considerable capacity to mutate, and the fact that there is still so much to learn about them, it is imperative to adopt a big picture, ecosystem approach to supporting immunity to increase the chance of safe and effective support. Thankfully, nature has provided us with just the tool kit required to face this challenge.


  1. The Silent Pandemic: Covid-19 and mental health | Feature from King’s College London [Internet]. [cited 2020 Dec 31].
  2. Islam MF, Cotler J, Jason LA. Post-viral fatigue and COVID-19: lessons from past epidemics. Fatigue Biomed Heal Behav [Internet]. 2020 Apr 2 [cited 2020 Dec 31];8(2):61–9.
  3. Roossinck MJ. The good viruses: Viral mutualistic symbioses [Internet]. Vol. 9, Nature Reviews Microbiology. Nat Rev Microbiol; 2011 [cited 2021 Jan 4]. p. 99–108.
  4. Scarpellini E, Ianiro G, Attili F, Bassanelli C, De Santis A, Gasbarrini A. The human gut microbiota and virome: Potential therapeutic implications. Dig Liver Dis [Internet]. 2015;47(12):1007–12.
  5. Timoneda J, Rodríguez-Fernández L, Zaragozá R, Marín MP, Cabezuelo MT, Torres L, et al. Vitamin A deficiency and the lung [Internet]. Vol. 10, Nutrients. MDPI AG; 2018
  6. Zhao H, Zhang H, Wu H, Li H, Liu L, Guo J, et al. Protective role of 1,25(OH)2vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice. BMC Gastroenterol [Internet]. 2012 May 30
  7. Shi YY, Liu TJ, Fu JH, Xu W, Wu LL, Hou AN, et al. Vitamin D/VDR signaling attenuates lipopolysaccharide-induced acute lung injury by maintaining the integrity of the pulmonary epithelial barrier. Mol Med Rep [Internet]. 2016 Feb 1 [cited 2021 Jan 4];13(2):1186–94.
  8. Cantorna MT, Snyder L, Arora J. Vitamin A and vitamin D regulate the microbial complexity, barrier function, and the mucosal immune responses to ensure intestinal homeostasis. Crit Rev Microbiol [Internet]. 2018 [cited 2020 Mar 20];54(2):184–12.
  9. Roscioli E, Jersmann HPA, Lester S, Badiei A, Fon A, Zalewski P, et al. Zinc deficiency as a codeterminant for airway epithelial barrier dysfunction in an ex vivo model of COPD. Int J COPD [Internet]. 2017 Dec 5 [cited 2021 Jan 4];12:3503–10.
  10. Carr AC, Maggini S. Vitamin C and immune function [Internet]. Vol. 9, Nutrients. MDPI AG; 2017
  11. Sirisinha S. The pleiotropic role of vitamin A in regulating mucosal immunity. Asian Pac J Allergy Immunol. 2015;33(2):71–8.
  12. Ohashi W, Fukada T. Contribution of Zinc and Zinc Transporters in the Pathogenesis of Inflammatory Bowel Diseases. 2019 [cited 2020 Mar 20];
  13. Maghbooli Z, Sahraian MA, Ebrahimi M, Pazoki M, Kafan S, Tabriz HM, et al. Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection. PLoS One [Internet]. 2020 Sep 1 [cited 2020 Dec 21];15(9 September).
  14. Jothimani D, Kailasam E, Danielraj S, Nallathambi B, Ramachandran H, Sekar P, et al. COVID-19: Poor outcomes in patients with zinc deficiency. Int J Infect Dis. 2020 Nov 1;100:343–9.
  15. Holford P, Carr AC, Jovic TH, Ali SR, Whitaker IS, Marik PE, et al. Vitamin C—An Adjunctive Therapy for Respiratory Infection, Sepsis and COVID-19. Nutrients [Internet]. 2020 Dec 7 [cited 2021 Jan 4];12(12):3760.
  16. Gohil K, Samson R, Dastager S, Dharne M. Probiotics in the prophylaxis of COVID-19: something is better than nothing [Internet]. Vol. 11, 3 Biotech. Springer Science and Business Media Deutschland GmbH; 2021 [cited 2020 Dec 21].
  17. Olaimat AN, Aolymat I, Al-Holy M, Ayyash M, Abu Ghoush M, Al-Nabulsi AA, et al. The potential application of probiotics and prebiotics for the prevention and treatment of COVID-19. npj Sci Food [Internet]. 2020 Dec 1 [cited 2021 Jan 4];4(1).
  18. Dhar D, Mohanty A. Gut microbiota and Covid-19- possible link and implications. Vol. 285, Virus Research. Elsevier B.V.; 2020. p. 198018.
  19. Malhotra A, Kamepalli RK, Bamrah JS. Perspective: Poor metabolic health is a major issue for increased COVID-19 mortality in BAME groups. The Physician [Internet]. 2020 Jul 8 [cited 2020 Dec 21];6(2).
  20. Miller MA, Cappuccio FP. A systematic review of COVID-19 and obstructive sleep apnoea [Internet]. Vol. 55, Sleep Medicine Reviews. W.B. Saunders Ltd; 2021
  21. Wang QQ, Xu R, Volkow ND. Increased risk of COVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States. World Psychiatry [Internet]. 2020 [cited 2021 Jan 4];
  22. Hossain MS, Urbi Z, Sule A, Rahman KMH. Andrographis paniculata (Burm. f.) Wall. ex Nees: A review of ethnobotany, phytochemistry, and pharmacology. Sci World J. 2014;2014.
  23. Hu XY, Wu RH, Logue M, Blondel C, Lai LYW, Stuart B, et al. Correction: Andrographis paniculata (Chuān Xīn Lián) for symptomatic relief of acute respiratory tract infections in adults and children: A systematic review and metaanalysis(PLoS ONE (2018) 12:8 (e0181780) DOI: 10.1371/journal.pone.0181780). PLoS One. 2018;13(11):1–30.
  24. Banerjee A, Czinn SJ, Reiter RJ, Blanchard TG. Crosstalk between endoplasmic reticulum stress and anti-viral activities: A novel therapeutic target for COVID-19 [Internet]. Vol. 255, Life Sciences. Elsevier Inc.; 2020 [cited 2021 Jan 4]. p. 117842.
  25. Sa-Ngiamsuntorn K, Suksatu A, Pewkliang Y, Thongsri P, Kanjanasirirat P, Manopwisedjaroen S, et al. Anti-SARS-CoV-2 activity of Andrographis paniculata extract and its major component Andrographolide in human lung epithelial cells and cytotoxicity evaluation in major organ cell representatives. bioRxiv [Internet]. 2020 Dec 8 [cited 2021 Jan 11];2020.12.08.415836. Available from:
  26. Chen JX, Xue HJ, Ye WC, Fang BH, Liu YH, Yuan SH, et al. Activity of andrographolide and its derivatives against influenza virus in vivo and in vitro. Biol Pharm Bull [Internet]. 2009 Aug [cited 2021 Jan 4];32(8):1385–91. Available from:
  27. Pleschka S, Stein M, Schoop R, Hudson JB. Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian Influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV). Virol J. 2009;6:1–9.
  28. Schapowal A, Klein P, Johnston SL. Echinacea Reduces the Risk of Recurrent Respiratory Tract Infections and Complications: A Meta-Analysis of Randomized Controlled Trials. Adv Ther. 2015;32(3):187–200.
  29. Venthan J. Mailoo SR. Lysine for Herpes Simplex Prophylaxis: A Review of the Evidence. Integr Med [Internet]. 2017 [cited 2019 Jul 8];16(3):42–6. Available from:
  30. Powell M. Medicinal mushrooms: A clinical guide. East Sussex: Mycology Press; 2010.
  31. Wachtel-Galor S, Yuen J, Buswell JA, Benzie IFF. Ganoderma lucidum (lingzhi or reishi): A medicinal mushroom. In: Herbal Medicine: Biomolecular and Clinical Aspects: Second Edition [Internet]. CRC Press; 2011 [cited 2020 Nov 2]. p. 175–99. Available from:
  32. Lin BQ, Li SP. Cordyceps as an herbal drug. In: Herbal Medicine: Biomolecular and Clinical Aspects: Second Edition [Internet]. CRC Press; 2011 [cited 2020 Nov 2]. p. 73–105. Available from:

Related Articles

GI Microbiome, Immunology & Inflammation
IBD & The Microbiome

The range of disorders cumulatively known as IBD affects many people across the UK, and the human microbiome is involved in more ways than one. The question is, what can ...

GI Microbiome, Supplements, Vaginal Microbiome
GOS – A Targeted Prebiotic in Your Microbiome Toolkit

With so many different types of prebiotics available, ranging from partially hydrolysed guar gum (PHGG) and galacto-oligosaccharide (GOS) to aronia berry and pomegranate, the clinical question of "which prebiotic?" is ...

GI Microbiome, Immunology & Inflammation
Iron Absorption and The Gut Microbiota

Iron deficiency is one of the most common micronutrient deficiencies worldwide, affecting around two billion people globally. For this reason, there has been a growing interest in understanding the interaction ...